Zobrazeno 1 - 10
of 32
pro vyhledávání: '"Bryon A Tompkins"'
Autor:
Angela C. Rieger, Robert J. Myerburg, Victoria Florea, Bryon A. Tompkins, Makoto Natsumeda, Courtney Premer, Aisha Khan, Ivonne H. Schulman, Mayra Vidro-Casiano, Darcy L. DiFede, Alan W. Heldman, Raul Mitrani, Joshua M. Hare
Publikováno v:
EBioMedicine, Vol 48, Iss , Pp 377-385 (2019)
Background: Non-ischemic dilated cardiomyopathy (NIDCM) responds variably to intramyocardial injection of mesenchymal stem cells (MSCs). We hypothesized that NIDCM genotype may influence responsiveness to MSC therapy and performed genotyping on all p
Externí odkaz:
https://doaj.org/article/01163b8467294193ba83ca5763e1cefa
Publikováno v:
Journal of Cardiac Surgery. 37:2884-2887
Autor:
Angela C Rieger, Bryon A Tompkins, Makoto Natsumeda, Victoria Florea, Monisha N Banerjee, Jose Rodriguez, Marcos Rosado, Valeria Porras, Krystalenia Valasaki, Lauro M Takeuchi, Kevin Collon, Sohil Desai, Michael A Bellio, Aisha Khan, Nilesh D Kashikar, Ana Marie Landin, Darrell V Hardin, Daniel A Rodriguez, Wayne Balkan, Joshua M Hare, Ivonne Hernandez Schulman
Publikováno v:
Stem Cells Translational Medicine. 11:59-72
Background Left ventricular hypertrophy and heart failure with preserved ejection fraction (HFpEF) are primary manifestations of the cardiorenal syndrome in patients with chronic kidney disease (CKD). Therapies that improve morbidity and mortality in
Autor:
Bryon A. Tompkins, Angela C. Rieger, Victoria Florea, Monisha N. Banerjee, Makoto Natsumeda, Evan D. Nigh, Ana Marie Landin, Gianna M. Rodriguez, Konstantinos E. Hatzistergos, Ivonne Hernandez Schulman, Joshua M. Hare
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 7, Iss 14 (2018)
Background Ischemic cardiomyopathy (ICM) and dilated cardiomyopathy (DCM) differ in histopathology and prognosis. Although transendocardial delivery of mesenchymal stem cells is safe and provides cardiovascular benefits in both, a comparison of mesen
Externí odkaz:
https://doaj.org/article/f20646039bc24ed7a1aed7ff8eb84856
Off pump coronary artery bypass in patients with an ejection fraction of <20%. What is our strategy?
Autor:
Tomas A. Salerno, Alejandro E. Macias, Bryon A. Tompkins, Daniel H. Buitrago, Michael Magarakis
Publikováno v:
Journal of Cardiac Surgery. 36:1067-1071
Patients with left ventricular dysfunction and low ejection fraction (EF) are at high risk of complication and mortality after coronary artery bypass grafting (CABG). The potential success of off-pump CABG in this high-risk population has yet to be i
Autor:
Victoria Florea, Angela C. Rieger, Alan W. Heldman, Makoto Natsumeda, Darcy L. DiFede, Aisha Khan, Mayra Vidro-Casiano, Raul Mitrani, Bryon A. Tompkins, Joshua M. Hare, Courtney Premer, Robert J. Myerburg, Ivonne Hernandez Schulman
Publikováno v:
EBioMedicine
EBioMedicine, Vol 48, Iss, Pp 377-385 (2019)
EBioMedicine, Vol 48, Iss, Pp 377-385 (2019)
Background: Non-ischemic dilated cardiomyopathy (NIDCM) responds variably to intramyocardial injection of mesenchymal stem cells (MSCs). We hypothesized that NIDCM genotype may influence responsiveness to MSC therapy and performed genotyping on all p
Autor:
Tomas A. Salerno, Bryon A. Tompkins
Publikováno v:
The Journal of Thoracic and Cardiovascular Surgery. 162:1120-1121
Autor:
Lauro M Takeuchi, Angela C Castellanos, Monisha N. Banerjee, Aisha Khan, Wayne Balkan, Daniel A. Rodriguez, Ivonne Hernandez Schulman, Victoria Florea, Michell Bellio, Joshua M. Hare, Jose Rodriguez, Darrell Hardin, Marcos Rosado, Bryon A. Tompkins, Makoto Natsumeda, Kristalenia Valasaki, Sohil S. Desai
Publikováno v:
Circulation Research. 127
Background: Heart failure with preserved ejection fraction (HFpEF) is a heterogeneous condition involving multiple comorbidities. Phenotypic classification of HFpEF associated with chronic kidney disease (CKD) manifests worse outcomes, compared to ot
Autor:
Matthias Loebe, Michael Magarakis, Bryon A. Tompkins, Tomas A. Salerno, Randas J. V. Batista, Victor S. Reis, Alejandro E. Macias
Publikováno v:
Journal of Cardiac Surgery. 33:597-602
Although Chagas disease is a rare entity in North America, it is associated with significant cardiac morbidity. It is estimated that 20-30% of those who are infected will eventually develop cardiovascular disease secondary to Chagas disease. We revie
Autor:
Wayne Balkan, Francisco Fernández-Avilés, Bryon A. Tompkins, Joshua M. Hare, Johannes Winkler, Georg Goliasch, Mariann Gyöngyösi
Publikováno v:
Circ Res
The recent scientific statement of the transnational alliance for regenerative therapies in cardiovascular syndromes (TACTICS) provided an overview of the many challenges associated with pre-clinical and clinical studies of stem cell therapy for HF(1